Follicle-stimulating hormone (FSH) may also be involved in decreasing bone mineral density during menopause, according to new research at the Medical College of Georgia in Augusta, GA. Diminished bone ...

New research suggests that hormone, follicle-stimulating hormone may be involved in decreasing bone mineral density during menopause. Diminished bone density is common among menopausal women and ...

Feeling persistently cold, especially in your hands and feet, can be a sign of iron-deficiency anemia—a condition in which ...

Higher follicle-stimulating hormone (FSH) levels were associated with lower hippocampal volumes in postmenopausal women, ...

In patients with amenorrhea and infertility, increased levels of serum luteinizing hormone and follicle-stimulating hormone are usually due to primary gonadal failure, whereas a selective increase in ...

Epidemiological data have implicated the pituitary gonadotropin follicle stimulating hormone (FSH) as both a risk factor for and a protective agent against epithelial ovarian cancer. Yet, little is ...

In all, 307 TCSs treated from 1980 to 1994 provided blood samples after orchiectomy but before further treatment, at Survey I (SI; 1998-2002), and Survey II (SII; 2007-2008). Levels of sex hormones ...

Diminished bone density is common among menopausal women and raises their risk of osteoporosis, bone fractures and subsequent complications. Research has traditionally focused on therapies that seek ...